Champlain Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hamilton Lane
HLNE
|
+$116M |
| 2 |
Trade Desk
TTD
|
+$111M |
| 3 |
Fastenal
FAST
|
+$99.4M |
| 4 |
Idexx Laboratories
IDXX
|
+$97.5M |
| 5 |
Wingstop
WING
|
+$93.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Penumbra
PEN
|
+$169M |
| 2 |
Everest Group
EG
|
+$167M |
| 3 |
Keysight
KEYS
|
+$153M |
| 4 |
J.M. Smucker
SJM
|
+$145M |
| 5 |
Cullen/Frost Bankers
CFR
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.72% |
| 2 | Industrials | 21.95% |
| 3 | Healthcare | 20.11% |
| 4 | Financials | 16.16% |
| 5 | Consumer Staples | 10.67% |
Similar funds
Champlain Investment Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Champlain Investment Partners held 150 positions worth $13.8B, down 13% from $15.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Champlain Investment Partners withdrew a net $910M in Q1 2025, closing 11 positions and reducing 84 holdings. Its most notable exit was Keysight, an estimated $153M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Champlain Investment Partners opened a new position in Hamilton Lane worth $113M.
- Champlain Investment Partners's largest Q1 2025 buy was Hamilton Lane: 759,313 shares worth $113M.
- Champlain Investment Partners added most to Fastenal in Q1 2025, an estimated $99.4M increase.
- Champlain Investment Partners's biggest Q1 2025 reduction was Penumbra, cutting an estimated $169M.
- Champlain Investment Partners fully exited Keysight in Q1 2025, selling an estimated $153M.
- Champlain Investment Partners's ten largest holdings make up 17% of its $13.8B portfolio in Q1 2025.
- Champlain Investment Partners opened 17 new positions and closed 11 in Q1 2025.
- Champlain Investment Partners's portfolio value fell 13% quarter-over-quarter to $13.8B.
Based on Champlain Investment Partners's 13F filing for Q1 2025, filed 14 May 2025.